HUMDFHua Medicine

About Hua Medicine (HUMDF)

Hua Medicine (HUMDF) is a Drug Manufacturers - Specialty & Generic company headquartered in Shanghai, China whose shares trade over-the-counter on the Pink tier.

Hua is a leading, clinical stage innovative drug development company in China focused on novel therapies for the treatment of diabetes. Founded by an experienced group of entrepreneurs and international investment firms, Hua advanced a first-in-class oral drug for the treatment of Type 2 Diabetes into NDA enabling stage and started 2 Phase 3 trials in China for drug naive and metformin treated T2D patients. The company also has initiated product life-cycle management studies of this novel diabetes drug, and advanced knowledge in personalized diabetes care. Hua's strategy is to leverage the cost-efficient and high-quality drug development capabilities available in China, while working very closely with disease experts in China and rest of world to advance diabetes care solutions for global patients.

HUMDF key facts

Ticker symbol

HUMDF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Shanghai, China

Country of incorporation

KY

Reporting standard

International Reporting: Hong Kong Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with H